Article
[A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase].
Annales de biologie clinique - 1 Jan 2000
Joly P, Bon C, Francina A, Gelineau M-C, Lacan P, Orfeuvre H
Abstract excerpt
We present here the case-report of a man with a severe G6PD deficiency revealed after the use of rasburicase (uricolytic drug) during a chemotherapy protocol. The genotypic analysis done to confirm the biochemical measurement revealed the 'Mediterranean mutation' at the hemizygous state (G6PD gen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.